Circulating Tumor DNA Monitoring in Breast Cancer Undergoing Neoadjuvant Therapy

Clinical Application of Circulating Tumor DNA (ctDNA) in Patients With Late-stage Breast Cancer

NCT05079074 ·Status: COMPLETED

Clinical Application of ctDNA Dynamic Monitoring in Neoadjuvant Therapy for HER2-positive Breast Cancer Patients

NCT06479460 ·Status: RECRUITING

Prognostic Value of Circulating Tumor DNA Dosing in Patients in Neoadjuvant Breast Neoplasia

NCT05050890 ·Status: UNKNOWN

ctDNA Monitoring in Early Breast Cancer

NCT04353557 ·Status: RECRUITING

Genomic Markers for Measuring Breast Cancer Response to Neoadjuvant Chemotherapy

NCT03709134 ·Status: COMPLETED

Evaluation of Treatment Efficacy by Circulating Tumor Cell Phenotype Surveillance in Breast Cancer Patients

NCT05326295 ·Status: RECRUITING

Clinical Application of CTDNA in Operable Breast Cancer Patients

NCT02797652 ·Status: UNKNOWN

Pre-analytical Factors Affecting ctDNA Analysis in Early and Locally Advanced Breast Cancer

NCT05945290 ·Status: COMPLETED

Monitoring Plasma Tumor DNA in Early-Stage Breast Cancer

NCT02743910 ·Status: ACTIVE_NOT_RECRUITING

Discerning the Impact of ctDNA Detection on Patient Decision Making in Early Stage Breast Cancer: a Conjoint Analysis

NCT05730010 ·Status: COMPLETED

Study on Early Auxiliary Diagnosis and Postoperative Recurrence Monitoring of Breast Cancer

NCT05858242 ·Status: RECRUITING

Clinical Value of Next Generation Sequencing in Endocrine Therapy for Advanced Hormone Receptor Positive/HER-2 Negative Breast Cancer

NCT03786575 ·Status: UNKNOWN ·Phase: NA

Detecting Circulating Tumor Cells (CTCs) and Cell Free DNA (cfDNA) in Peripheral Blood of Breast Cancer (BC) Patients to Develop the Clinical Application for Early Detection and Diagnostics

NCT03511859 ·Status: UNKNOWN

Correlation Between Molecular Typing and Neoadjuvant Chemotherapy in Breast Cancer Patients Based on Mammaprint/Blueprint Test

NCT04264468 ·Status: UNKNOWN

Clinical Application of ctDNA in Early Screening of Breast Cancer

NCT03973034 ·Status: UNKNOWN

Circulating Tumor DNA and Immunophenotyping as Potential Biomarkers With Regional Nodal Irradiation for Breast Cancer

NCT04308720 ·Status: ACTIVE_NOT_RECRUITING

Safe De-escalation of Chemotherapy for Stage 1 Breast Cancer

NCT05058183 ·Status: RECRUITING ·Phase: NA

Breast-Specific Gamma Imaging and Locally Advanced Breast Cancer Undergoing Neoadjuvant Chemotherapy

NCT02556684 ·Status: UNKNOWN

Genetic Markers of Circulating Tumor DNA for Monitoring Breast Cancer Patients in Costa Rica

NCT04163159 ·Status: UNKNOWN

Exploratory Research on Constructing a Computational Biological Model Based on NGS for MRD After Breast Cancer Surgery

NCT06595966 ·Status: RECRUITING

Circulating Tumor DNA to Guide Changes in Standard of Care Chemotherapy

NCT05770531 ·Status: RECRUITING ·Phase: PHASE2

Application of CfDNA Methylation Detection in Auxiliary Diagnosis of Breast Cancer

NCT06876610 ·Status: RECRUITING

Tumor Suppressor Status as a Predictor of Chemotherapy Response in Triple Negative Breast Cancer

NCT01514565 ·Status: UNKNOWN

Use of INnovative and Micro-INvasive TEchniques for the Early Identification of Breast Cancer Patients Benefitting From Neo-adjuvant Therapy

NCT05846997 ·Status: UNKNOWN

Correlation Between Serum TK1 and Pathological Remission of Breast Cancer With Neoadjuvant Chemotherapy

NCT06509555 ·Status: RECRUITING